Position in BMY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$6,745,342
-$1,006,698 QoQ
Shares Held
117,066
-8.4% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
2.67%
of 13F equity value
Holder Rank
#471
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 22%
Shared 0%
None 78%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BOURNE LENT ASSET MANAGEMENT INC holds $19,951,025 across 7 Drug Manufacturers - General names. BMY ranks #1 (33.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
This page
|
117,066 | $6,745,342 | |
| 2 | LLY |
ELI LILLY & Co
|
3,887 | $4,662,184 | |
| 3 | AMGN |
Amgen Inc
|
9,860 | $3,570,503 | |
| 4 | JNJ |
Johnson & Johnson
|
12,206 | $3,099,957 | |
| 5 | PFE |
Pfizer Inc
|
36,275 | $873,502 | |
| 6 | MRK |
Merck & Co., Inc.
|
4,357 | $559,874 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,480 | $439,663 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,745,342 | 117,066 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $7,752,040 | 127,816 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $6,905,183 | 128,016 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $5,869,359 | 130,141 | Shares | Sole | 2025-12-15 | |
| 2025-06-30 | $6,139,951 | 132,641 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $8,239,200 | 135,091 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $8,353,402 | 147,691 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $8,133,114 | 157,192 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $6,590,271 | 158,687 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $8,815,194 | 162,552 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $8,633,266 | 168,257 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $10,736,877 | 184,991 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $13,196,273 | 206,353 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $14,628,082 | 211,053 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $15,228,432 | 211,653 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $20,866,905 | 293,528 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $22,734,096 | 295,248 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $21,693,415 | 297,048 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $19,983,050 | 320,498 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $21,595,393 | 364,972 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $24,387,429 | 364,972 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $24,413,381 | 386,716 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $24,351,861 | 392,582 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $24,792,755 | 411,225 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $24,583,398 | 418,085 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $23,401,602 | 419,835 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||